Liu, P. Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action., Chin. J. Integr. Med. 18, 398–400 (2012). https://doi.org/10.1007/s11655-012-1030-1
Ping Liu. Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action[J]. Chinese Journal of Integrative Medicine, 2012,18(5):398-400.
Liu, P. Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action., Chin. J. Integr. Med. 18, 398–400 (2012). https://doi.org/10.1007/s11655-012-1030-1DOI:
Ping Liu. Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action[J]. Chinese Journal of Integrative Medicine, 2012,18(5):398-400. DOI: 10.1007/s11655-012-1030-1.
Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action
摘要
Liver fibrosis represents the wound healing response to liver injury from a wide variety of etiologies. Remarkable progresses have been shown in the field of liver fibrosis in a range of areas in the past years. In particular
the reversibility of liver fibrosis has been well documented in both patients and animal models. Great progresses have been made in the treatment of liver fibrosis with Chinese medicine. This review summarizes the effects of Fuzheng Huayu Capsule (扶正化瘀胶囊
FZHYC) in treating liver fibrosis and inflammation induced by chronic hepatitis B in clinical trials and the mechanism of action of FZHYC in reversing liver fibrosis in vivo and in vitro experiments.
Abstract
Liver fibrosis represents the wound healing response to liver injury from a wide variety of etiologies. Remarkable progresses have been shown in the field of liver fibrosis in a range of areas in the past years. In particular
the reversibility of liver fibrosis has been well documented in both patients and animal models. Great progresses have been made in the treatment of liver fibrosis with Chinese medicine. This review summarizes the effects of Fuzheng Huayu Capsule (扶正化瘀胶囊
FZHYC) in treating liver fibrosis and inflammation induced by chronic hepatitis B in clinical trials and the mechanism of action of FZHYC in reversing liver fibrosis in vivo and in vitro experiments.
关键词
Liver FibrosisChinese MedicineFuzheng Huayu CapsuleClinical Studymechanism of action
Keywords
Liver FibrosisChinese MedicineFuzheng Huayu CapsuleClinical Studymechanism of action
references
Friedman SL. Liver fibrosis — from bench to bedside. J Hepatol 2003; (38 Suppl 1):S38–S53.
Friedman SL. Reversibility of hepatic fibrosis and cirrhosis—is it all hype? Nat Clin Pract Gastroenterol Hepatol 2007;4:236–237.
Wang HJ, Wang BE. The long-term therapeutic efficacy of compound Radix Salvia Miltiorrhiza Granule (861 Granule) in treating liver fibrosis. Chin J Integr Tradit West Med Liver Dis (Chin) 1995;5:4–5
Liu P, Liu C, Hu YY. Effect of Fuzheng Huayu Recipe in treating posthepatitic cirrhosis. Chin J Integr Tradit West Med (Chin) 1996;16:459–462.
Special Committee of Liver Diseases, Chinese Association of Integrative Medicine, Guideline for the diagnosis and treatment of liver fibrosis with integrative medicine. Chin J Integr Tradit West Med (Chin) 2006;26:1052–1056.
Wang YR. Review and prospect of traditional Chinese medicine in the treatment of advanced schistosome cirrhosis. Shanghai J Tradit Chin Med (Chin) 1985;6:7–10.
Xu LM, Liu P, Liu CH. Pathological and immunohistochemical study of extractum semen persiae and cordyceps hyphae in treating posthepatitic cirrhosis. J Tradit Chin Med (Chin) 1994;35:737–739.
Liu P, Liu C, Chen GC, Hu YY, Xu LM, Lv P, et al. Effect of Fuzheng Huayu 319 Recipe on serological parameters of fibrosis in treating chronic hepatitis B. Chin J Integr Tradit West Med (Chin) 1996;16:588–592.
Xu LM, Liu P, Liu C, Gu HT, Xue HM, Lv G, et al. Treatment of chronic hepatitis B and liver fibrosis with Fuzheng Huayu 319 Recipe. Chin J Hepatol (Chin) 1997; 5:207–209.
Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2002;8:679–685.
Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, et al. Multicenter clinical study on Fuzheng Huayu Capsule against liver fibrosis due to chronic hepatitis B. World J Gastroenterol 2005;11:2892–2899.
Hu YY, Liu P, Liu C, Liu CH, Xu LM. The value of serum markers in evaluating liver fibrotic changes. Chin J Hepatol (Chin) 2006;14:174–177.
Liu CH, Wang XL, Liu P. Serapharmacological effect of Fuzheng Huayu 319 Decoction on expression of type I collagen and transforming growth factor β 1 in hepatic stellate cells. Chin J Integr Tradit West Med (Chin) 1999;19:412–414.
Zhou T, Yan XC, Chen Q, Tao YY, Liu CH. Effect of Fuzheng Huayu Decoction on hepatocytic apoptosis and necrosis on acute hepatotoxin due to LPS in mice. Drug Eval (Chin) 2008;5:204–208.
Jiang CM, Liu C, Liu CH, Hu YY. Effect of Fuzheng Huayu Decoction (FZHYF) on the function of Kupffer cells from acute injury liver induced by CCl4. Chin J Integr Tradit West Med Liver Dis (Chin) 2000;10 (5):26–28.
Lu X, Liu P, Liu CH, Xu GF, Wang XB, et al. Role of hepatic sinusoidal endothelium injury in hepatic fibrogenesis induced by dimethylnitrosamine in rats. Chin J Hepatol (Chin) 2002;10:441–444.
Lu X, Liu P, Liu CH, Xu GF, Li FH, Gu HT, et al. Experimental study for role of Fu Zheng Hua Yu Recipe on promoting reversion of hepatic sinusoid capillarization induced by dimethylnitrosamine in rats. J Chin Med (Chin) 2003;44:136–139.
Effects and mechanisms of actions of Chinese herbal medicines for asthma
The potential role of Chinese medicine in ameliorating extra-articular manifestations of rheumatoid arthritis
Significance of evidence-based medicine in the assessment of Chinese medicine clinical efficacy
Progress of research in antitumor mechanisms with Chinese medicine
Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture
相关作者
暂无数据
相关机构
Center for Chinese Medicine for Allergy and Asthma, Jaffe Food Allergy Institute, Pediatric Department, Division of Allergy and Immunology, The Mount Sinai School of Medicine
Respiratory Department, Zhangzhou Traditional Chinese Medicine Hospital, Affiliated Hospital of Fujian University of Traditional Chinese Medicine
Department of Rheumatology, The First Affiliated Hospital of Anhui College of Traditional Chinese Medicine
Zhongshan Hospital Affiliated to Fudan University
Beijing Cancer Hospital & Institute, Peking University School of Oncology